Dental News - Geistlich Biomaterials to offer ‘Multidisciplinary Treatment Solutions for Peri-Implantitis Symposium’

Search Dental Tribune

Geistlich Biomaterials to offer ‘Multidisciplinary Treatment Solutions for Peri-Implantitis Symposium’

(Photos: Geistlich Biomaterials)

Fri. 31 March 2017

save

Geistlich Pharma North America Inc. is proud to announce, with its symposium sponsors, an interactive and didactic program covering topics around peri-implantitis. “Multidisciplinary Treatment Solutions for Peri-Implantitis,” a three-day event taking place June 9 to 11 in Chicago, will feature a surgical and non-surgical hands-on workshop as well as general sessions from world-class presenters.

This multidisciplinary symposium is for all dental professionals who are responsible for or interested in the placement, maintenance, restoration and preservation of dental implants.

“Peri-implantitis is not a regional problem; it’s a worldwide problem, so coming together [at this symposium] for hands-on training and an honest discussion about what we know and what we still need to learn is what this conference will be all about,” said Dr. Stuart Froum, co-organizing chairman. “It will stress a multidisciplinary approach with both surgeons and restorative dentists learning how collaboration on diagnosis and treatment can increase successful outcomes.”

Global exchange of high-level ideas and information will be carried throughout the event. The hands-on workshops, on June 9, will be limited in attendance and are sure to sell out quickly.

These interactive programs will review “Non-Surgical Periodontal Therapy,” presented by Dr. Marisa Roncati of Italy, and “Corrections for the Prevention and Management of Peri-Implant Diseases,” presented by Prof. Dr. Frank Schwarz of Germany.

General sessions will take place on June 10 and June 11 and will include topics such as:

  • “Prevent Peri-Implantitis and Plan for Long-Term Success,” presented by Dr. Myron Nevins, U.S.
  • “Identifying Factors Associated with Peri-Implant Bone Loss,” presented by Dr. Paul Rosen, U.S.
  • “Surgical Regenerative Therapy of Peri-Implantitis,” presented by Prof. Dr. Frank Schwarz, Germany
  • “Managing Peri-Implant Disease From a Laser Perspective,” presented by Dr. Sam Low, U.S.
  • “Peri-Implant Diseases: Understanding Etiology and Risk,” presented by Dr. Joseph Fiorellini, U.S.
  • “A Regenerative Algorithm for the Treatment of Peri-Implantitis,” presented by Dr. Froum, U.S.
  • “Peri-Implantitis Associated with Machined or Rough Surfaces,” presented by Dr. Massimo Simion, Italy
  • “Peri-Implant Disease and the Restorative Dentist,” presented by Dr. Chandur Wadhwani, U.S.
  • “Is it Possible to Restore the Complete Health Around Implants Affected from Peri-Implant Disease?” presented by Dr. Marco Ronda, Italy
  • “What Role Does the Restoration of Implants Play in Peri-Implantitis?” Dr. Stephen Chu, U.S.

More details on the symposium can be found at http://www.geistlich-na.com/en-us/events/symposium/peri-implantitis-symposium/.

About Geistlich Pharma North America Inc.

Geistlich Pharma North America continues to lead dental regeneration with its expanding family of predictable and proven biomaterials, including bone substitutes Geistlich Bio-Oss and Geistlich Bio-Oss Collagen, a resorbable bilayer collagen membrane, Geistlich Bio-Gide, a soft-tissue regeneration collagen matrix, Geistlich Mucograft and introducing Geistlich Mucograft Seal, a 3-D collagen matrix designed for soft-tissue regeneration with an implant or prosthetic. With more than 160 years of Swiss tradition, Geistlich Biomaterials has been a trusted partner for dental regenerative solutions based upon continuous innovation and scientific collaboration.

(Source: Geistlich Biomaterials)

 

To post a reply please login or register
advertisement
advertisement